Company Financials

Kiniksa Pharmaceuticals, Ltd. Financials

United States dollar

business Kiniksa Pharmaceuticals, Ltd. Company Profile

Main Stock Listing

NASDAQ: KNSA

Market Capitalization $3.18 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 91.67
Forward PE 22.39
Price to Sales TTM $5.23
Price to Book MRQ $5.81
Enterprise to Revenue 4.66
Enterprise to EBITDA 70.24

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin 6.01%
Operating Margin 13.28%
Return on Assets TTM 3.76%
Return on Equity TTM 7.39%

Income Statement

Revenue TTM $597,972,992
Revenue per Share TTM $8.16
Quarterly Revenue Growth 61.20%
Gross Profit TTM $315,644,992
EBITDA $39,641,000
Net Income to Common TTM $35,918,000
Diluted EPS TTM $0.45
Quarterly Earnings Growth YoY 61.17%

Balance Sheet

Total Cash MRQ $352,102,016
Total Cash per Share MRQ $4.65
Total Debt MRQ $
Total Debt to Equity MRQ 1.82
Current Ratio MRQ 3.85
Book Value per Share MRQ $7.10

Cash Flow

Operating Cash Flow TTM $102,861,000
Levered Free Cash Flow TTM $50,336,248

KNSA Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 75,424,653
Float Shares 35,166,200
Avg 10 Volume 379,050
Avg 30 Volume None
Shares Short 3,103,773
Short Ratio 8.32
Short % of Shares 7.43%
% Held by Insiders 3.56%
% Held by Institutions 92.04%

Stock Price Summary

Beta 0.01
Fifty Two Week Low $17.82
Fifty Two Week High $44.42
Fifty Two Week Change 52.34%
Day 50 MA $40.63
Day 200 MA $32.28

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date